Nicotine consumption and Parkinson's disease--does the smoke clear up?
Vieregge
P
P
Heberlein
I
I
D000368:Aged; D000818:Animals; D001921:Brain / Q000503:physiopathology; D002352:Carrier Proteins / Q000502:physiology; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D008099:Liver / Q000503:physiopathology; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D009538:Nicotine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D010300:Parkinson Disease / Q000503:physiopathology*; D012907:Smoking / Q000009:adverse effects / Q000503:physiopathology*; D016540:Smoking Cessation
D002352:Carrier Proteins; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D009538:Nicotine